These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 35589644
1. [Treatment of Dermatomyositis and Immune-Mediated Necrotizing Myopathy with Poor Muscle Recovery with Steroids and IVIg: Intractable Dermatomyositis and Immune-Mediated Necrotizing Myopathy]. Sugie K. Brain Nerve; 2022 May; 74(5):537-544. PubMed ID: 35589644 [Abstract] [Full Text] [Related]
2. [Treatment of Dermatomyositis and Immune-Mediated Necrotizing Myopathy with Poor Muscle Recovery with Steroids and IVIg: Therapeutic Strategies for Refractory Inflammatory Myositis]. Tomimitsu H. Brain Nerve; 2022 May; 74(5):545-552. PubMed ID: 35589645 [Abstract] [Full Text] [Related]
3. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)]. Tournadre A. Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868 [Abstract] [Full Text] [Related]
4. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use. Gandiga PC, Ghetie D, Anderson E, Aggrawal R. Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663 [Abstract] [Full Text] [Related]
10. [Idiopathic inflammatory myopathies. A review]. Acosta I, Matamala JM, Jara P, Pino F, Gallardo A, Verdugo R. Rev Med Chil; 2019 Mar 01; 147(3):342-355. PubMed ID: 31344172 [Abstract] [Full Text] [Related]
11. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. Dalakas MC. J Clin Immunol; 1995 Nov 01; 15(6 Suppl):70S-75S. PubMed ID: 8613495 [Abstract] [Full Text] [Related]
12. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin. Shahani L. BMJ Case Rep; 2012 Aug 18; 2012():. PubMed ID: 22907859 [Abstract] [Full Text] [Related]
13. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis. Aslanidis S, Pyrpasopoulou A, Kartali N, Zamboulis C. Clin Rheumatol; 2007 Jul 18; 26(7):1198-200. PubMed ID: 16779504 [Abstract] [Full Text] [Related]
14. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy. Soubrier C, Seguier J, Di Costanzo MP, Ebbo M, Bernit E, Jean E, Veit V, Swiader L, Salort-Campana E, Attarian S, De Paula AM, Kaplanski G, Durand JM, Harlé JR, Schleinitz N. Clin Rheumatol; 2019 Dec 18; 38(12):3451-3458. PubMed ID: 31440919 [Abstract] [Full Text] [Related]
15. Idiopathic inflammatory myopathies. Dimachkie MM, Barohn RJ. Front Neurol Neurosci; 2009 Dec 18; 26():126-146. PubMed ID: 19349710 [Abstract] [Full Text] [Related]
16. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis]. Breems DA, de Haas PW, Visscher F, Sabbe LJ, Busch HF, van Doorn PA. Ned Tijdschr Geneeskd; 1993 Sep 25; 137(39):1979-82. PubMed ID: 8413708 [Abstract] [Full Text] [Related]
17. Idiopathic inflammatory myopathies. van der Kooi AJ, de Visser M. Handb Clin Neurol; 2014 Sep 25; 119():495-512. PubMed ID: 24365315 [Abstract] [Full Text] [Related]
18. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre. Loarce-Martos J, Lilleker JB, Parker M, McHugh N, Chinoy H. Rheumatology (Oxford); 2021 Jul 01; 60(7):3398-3403. PubMed ID: 33367878 [Abstract] [Full Text] [Related]
19. [Inflammatory muscle diseases]. Pongratz D. Z Rheumatol; 1986 Jul 01; 45(4):133-8. PubMed ID: 3776360 [Abstract] [Full Text] [Related]